|
1）Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med. 1997; 336: 1365-72
|
|
|
|
2）Young NS. Acquired aplastic anemia. Ann Intern Med. 2002; 136: 534-46
|
|
|
|
|
|
3）Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009; 147: 43-70
|
|
|
|
|
|
4）Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012; 120: 1185-96
|
|
|
|
|
|
5）Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993; 329: 1152-7
|
|
|
|
|
|
6）Najean Y, Haguenauer O. Long-term (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood. 1990; 76: 2222-8
|
|
|
|
|
|
7）Tisdale JF, Maciejewski JP, Nunez O, et al. Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood. 2002; 100: 4668-70
|
|
|
|
|
|
8）Dameshek W. Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common? Blood. 1967; 30: 251-4
|
|
|
|
|
|
9）Josten KM, Tooze JA, Borthwick-Clarke C, et al. Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood. 1991; 78: 3162-7
|
|
|
|
|
|
10）Griscelli-Bennaceur A, Gluckman E, Scrobohaci ML, et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood. 1995; 85: 1354-63
|
|
|
|
|
|
11）Katagiri T, Sato-Otsubo A, Kashiwase K, et al. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia. Blood. 2011; 118: 6601-9
|
|
|
|
|
|
12）Murakami Y, Kosaka H, Maeda Y, et al. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria. Blood. 2002; 100: 4116-22
|
|
|
|
|
|
13）Gargiulo L, Papaioannou M, Sica M, et al. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood. 2013; 121: 2753-61
|
|
|
|
|
|
14）Mathe G, Amiel JL, Schwarzenberg L, et al. Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J. 1970; 2: 131-6
|
|
|
|
|
|
15）Zoumbos NC, Gascon P, Djeu JY, et al. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med. 1985; 312: 257-65
|
|
|
|
|
|
16）Katagiri T, Qi Z, Ohtake S, et al. GPI-anchored protein-deficient T cells in patients with aplastic anemia and low-risk myelodysplastic syndrome: implications for the immunopathophysiology of bone marrow failure. Eur J Haematol. 2011; 86: 226-36
|
|
|
|
|
|
17）Hinterberger W, Adolf G, Aichinger G, et al. Further evidence for lymphokine overproduction in severe aplastic anemia. Blood. 1988; 72: 266-72
|
|
|
|
|
|
18）Mikhailova N, Sessarego M, Fugazza G, et al. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica. 1996; 81: 418-22
|
|
|
|
|
|
19）Wang H, Chuhjo T, Yasue S, et al. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood. 2002; 100: 3897-902
|
|
|
|
|
|
20）Vago L, Perna SK, Zanussi M, et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med. 2009; 361: 478-88
|
|
|
|
|
|
21）Villalobos IB, Takahashi Y, Akatsuka Y, et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood. 2010; 115: 3158-61
|
|
|
|
|
|
22）Issaragrisil S, Kaufman DW, Anderson T, et al. The epidemiology of aplastic anemia in Thailand. Blood. 2006; 107: 1299-307
|
|
|
|
|
|
23）Montane E, Ibanez L, Vidal X, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008; 93: 518-23
|
|
|
|
|
|
24）Shichishima T, Noji H, Ikeda K, et al. The frequency of HLA class I alleles in Japanese patients with bone marrow failure. Haematologica. 2006; 91: 856-7
|
|
|
|
|
|
25）Lane AA, Odejide O, Kopp N, et al. Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia. 2013; 27: 968-71
|
|
|
|
|
|
26）Kulasekararaj AG, Jiang J, Smith AE, et al. Somatic mutations identify a sub-group of aplastic anemia patients that progress to myelodysplastic syndrome. Blood. 2014; 124: 2698-704
|
|
|
|
|
|
27）Busque L, Patel JP, Figueroa ME, et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet. 2012; 44: 1179-81
|
|
|
|
|
|
28）Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014; in press
|
|
|
|
|